Discover three Indian stocks that have returned more than 100% year-to-date. In this article we break down their key metrics, growth context, and practical take-aways for retail investors. Do you have any in your portfolio?
When a stock delivers over 100% return year-to-date (YTD), it signals strong investor confidence and often accelerating business fundamentals. For retail investors and traders, such stocks offer both opportunity and caution: opportunity because the momentum is proven, caution because high return often comes with higher risk or higher expectations. In this article, we examine four Indian stocks that have cleared the 100% return threshold YTD which you should keep on your radar.
Stock 1: Valiant Communications Ltd.
Company:
Valiant Communications Ltd.
· CMP: ₹779.85
· Market
Capitalization: ₹892.31 crore
· P/E Ratio: 65.23
· ROCE: 21.13%
· ROE: 25.85%
· 1-Year Return: 102.81%
Valiant Communications has delivered a strong 103% return over the past year, backed by improving business visibility in the global telecom and networking segment. The company’s ROCE of 21.13% and ROE of 25.85% indicate solid operational efficiency and strong profitability.Company is debt-free.Company has delivered good profit growth of 109% over the last 5 years.The company is debt-free.
The higher P/E ratio of 65.23 suggests
that the stock is trading at a premium valuation, reflecting investors’
expectations of continued growth in exports and government contracts. Valiant’s
niche position in communication and synchronization products gives it a
competitive edge, and rising demand for secure data transmission is fueling
long-term potential. However, given the elevated valuation, investors should
keep an eye on earnings consistency before adding fresh exposure.
See the weekly chart
Stock 2: Hemant Surgical Industries Ltd.
Company: HSIL
· CMP: ₹288.00
· Market
Capitalization: ₹375.58 crore
· P/E Ratio: 46.91
· ROCE: 16.35%
· ROE: 13.58%
· 1-Year Return: 101.26%
Hemant Surgical has doubled investor wealth with
a 101% return in one year. The company, engaged in the
production and distribution of surgical and medical equipment, is benefiting
from rising healthcare infrastructure and hospital expansion in India.
The ROCE of 16.35% and ROE
of 13.58% highlight decent profitability and capital efficiency.
Its P/E ratio of 46.91 shows that the stock is valued
optimistically, yet justified by consistent earnings growth and expanding
product range. With India’s healthcare spending on an upward trend, Hemant
Surgical growth story looks sustainable in the medium term. Long-term
investors, however, should track margins and input costs closely as competition
in this space remains high.
See the weekly chart
Stock 3: Swadeshi Industries and Leasing Ltd.
Company:
· CMP: ₹96.06
· Market
Capitalization: ₹103.91 crore
· P/E Ratio: 78.13
· ROCE: 6.06%
· ROE: 6.14%
· 1-Year Return: 3440.60%
(Extraordinary)
Swadeshi Industries has delivered an unbelievable 3440% return in the past year — a figure rarely seen in the market. This extraordinary surge has turned it into one of the most talked-about multibagger stocks of 2025. However, the company’s ROCE of 6.06% and ROE of 6.14% indicate weak operational performance relative to its massive price appreciation.The company is almost debt-free.Debtor days have improved from 198 days to 121.Company has low return on equity of 1.43 over last 5 years.
Such a mismatch between fundamentals and stock
performance usually signals speculative interest or revaluation triggered by
low equity float or turnaround expectations. The P/E ratio of 78.13 is
extremely high, showing that valuations may have run far ahead of earnings.
While short-term traders might find momentum opportunities, investors should
approach with caution, as the sustainability of such massive gains depends on
tangible improvement in earnings and business execution.
Disclaimer: The information provided on MoneyWiseMind is for information purposes only, not a buy or sell recommendation. Please consult a licensed financial advisor before making any financial decisions.
